Impaired Death Receptor Signaling in Leukemia Causes Antigen-Independent Resistance by Inducing CAR T-cell DysfunctionNathan Singh, Marco Ruella, Sangya Agarwal et al.|Cancer Discovery|2020Cited by 297
Deletion of the inhibitory co-receptor CTLA-4 enhances and invigorates chimeric antigen receptor T cellsSangya Agarwal, Carl H. June, M. Ángela Aznar et al.|Immunity|2023Cited by 164
Potentiating adoptive cell therapy using synthetic IL-9 receptorsAnusha Kalbasi, K. Christopher García, Mikko Siurala et al.|Nature|2022Cited by 115
Abstract 5571: Disruption of cell-intrinsic checkpoint regulator CTLA-4 in CD19 directed CAR T cells provides clinical efficacy in CLL patientsSangya Agarwal, Carl H. June, David L. Porter et al.|Cancer Research|2022Cited by 2
Publisher Correction: Potentiating adoptive cell therapy using synthetic IL-9 receptorsAnusha Kalbasi, K. Christopher García, Mikko Siurala et al.|Nature|2022Cited by 2